Form 4 for ICE Intercontinental Exchange
Accepted 2022-02-25 00:00:00 ET · period of report 2022-02-23 · accession 0001209191-22-013205 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-02-25 | 2022-02-23 | ICE | Sprecher Jeffrey C | CEO, Dir | M - OptEx | $41.63 | +65.7K | 1.38M | +5% | +$2.73M |
| DM | 2022-02-25 | 2022-02-23 | ICE | Sprecher Jeffrey C | CEO, Dir | S - Sale+OE | $124.55 | -86.7K | 1.30M | -6% | -$10.80M |
| DM | 2022-02-25 | 2022-02-23 | ICE | Sprecher Jeffrey C | CEO, Dir | M - OptEx | $0.00 | -65.7K | 127.4K | -34% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-23 | M | A | 1,995 | $50.01 | 1,382,215 | D | — | — | (F1) The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. |
| 2 | Common | Common Stock | 2022-02-23 | S | D | 33,928 | $124.76 | 1,313,115 | D | — | — | (F1) The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. (F3) The price range for the aggregate amount sold by the direct holder is $124.28 - $125.27. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2022-02-23 | S | D | 35,172 | $123.82 | 1,347,043 | D | — | — | (F1) The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. (F2) The price range for the aggregate amount sold by the direct holder is $123.28 - $124.27. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2022-02-23 | S | D | 17,645 | $125.58 | 1,295,470 | D | — | — | (F1) The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. (F4) The price range for the aggregate amount sold by the direct holder is $125.28 - $126.09. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. (F5) The common stock number referred in Table I is an aggregate number and represents 1,235,626 shares of common stock and 59,844 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2022 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023 and will be reported at the time of vesting. The satisfaction of the 2020, 2021 and 2022 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023, February 2024 and February 2025, respectively, and will be reported at the time of vesting. |
| 5 | Common | Common Stock | 2022-02-23 | M | A | 63,680 | $41.37 | 1,380,220 | D | — | — | (F1) The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. |
| 6 | Derivative | Employee Stock Option (right to buy) Holding | 2022-02-23 | M | D | 1,995 | $0.00 | 175,165 | D | $50.01 · — to 2026-01-14 | 1,995 Common Stock | (F8) These options are fully vested. |
| 7 | Derivative | Employee Stock Option (right to buy) Holding | 2022-02-23 | M | D | 63,680 | $0.00 | 127,360 | D | $41.37 · — to 2024-01-17 | 63,680 Common Stock | (F8) These options are fully vested. |